Inasmuch as Downey was speaking at an event designed to promote the Teva-Barr merger to the investment community, would you honestly have expected him to question the impregnability of Teva’s Copaxone franchise?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”